Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient
NCT03859817 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 68
Last updated 2021-09-28
Summary
A multicentre real life study is proposed. The study has as its goal primary to compare the levels of ketonemia measured in patients with albuminuria and patients normo albuminurici to evaluate a possible correlation between ketone level and alteration of renal function in the diabetic patient, comparing the eGFR values of patients with ketonemia high and of patients with low ketonemia. In these patients, the lack of insulin causes one imbalance between ketogenesis and ketolysis, with increased production and reduced body clearance ketones. Several studies explore the effects of ketone bodies on cell function and lesions diabetic complications: ketonemia induces oxidative stress and increases the risk and the progression of complications, moreover, the increase in ketone levels may have pro-inflammatory effects. However, ketonemia levels between normal and DKA are poorly studied and their effects are still unknown. It is hypothesized that
* in diabetic patients with DKD the level of ketones may be high;
* Increased ketone levels may promote an alteration of renal function.
We want to evaluate the relationship between ketone levels and renal function, because the kidneys, as well as the heart, are among the main organs in which the ketone bodies are oxidized to produce energy and DKD has a high morbidity and mortality in diabetes. The main objectives for being able to demonstrate the hypothesis in question are:
* Evaluate the level of ketones in albuminurate patients with diabetes and in patients with renal function altered;
* Evaluate the association between ketone level and decline of renal function in the diabetic patient e therefore the impact of ketonemia on the progression of renal function loss.
Conditions
- Diabetic Nephropathy Type 2
Interventions
- OTHER
-
Comparison of eGFR values and ketonemia in diabetic patients
To verify if there is a correlation between the level of ketones and an alteration of the renal function in the diabetic patient, the values of the prognostic markers indicated in the protocol and the data downloaded by the glucometers will be evaluated in addition to the blood tests of the patients
Sponsors & Collaborators
-
University of Milan
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-16
- Primary Completion
- 2021-12-18
- Completion
- 2021-12-31
Countries
- Italy
Study Locations
More Related Trials
-
May Metformin be Used in Renal Failure?
NCT02710448 ·Status: COMPLETED ·Phase: PHASE2
-
Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study
NCT02848508 ·Status: WITHDRAWN ·Phase: PHASE2
-
Oxygen Therapy in Diabetic Kidney Disease
NCT06959485 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy
NCT00309127 ·Status: COMPLETED ·Phase: NA
-
Lipid Profile in Diabetic and Non Diabetic CKD Patients
NCT06802978 ·Status: RECRUITING
-
The Correlation Between HbA1c and Mean Blood Glucose in Patients With Diabetes and Renal Failure
NCT01937858 ·Status: TERMINATED
-
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
NCT02065791 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
NCT01989754 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
NCT04929379 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Mechanisms Underlying SGLT2i Kidney Effect in DKD Progression
NCT07270198 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
NCT06528405 ·Status: RECRUITING ·Phase: PHASE2
-
A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02)
NCT00830791 ·Status: TERMINATED ·Phase: PHASE1
-
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
NCT05715814 ·Status: RECRUITING ·Phase: PHASE3
-
Reducing Risk of Diabetic Ketoacidosis in Type 1 Diabetes and Kidney Disease Using Continuous Ketone Monitoring
NCT07325201 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes Mellitus
NCT01273558 ·Status: COMPLETED ·Phase: PHASE1
-
OPTIMISE-CKD Drug Utilization
NCT05932901 ·Status: COMPLETED
-
Molecular Analysis of Diabetic Kidney Disease Biopsies
NCT04029402 ·Status: RECRUITING
-
A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment
NCT01316094 ·Status: COMPLETED ·Phase: PHASE3
-
Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
NCT06182891 ·Status: COMPLETED ·Phase: NA
-
Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy
NCT05695573 ·Status: COMPLETED
-
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
NCT06068439 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
The Incretin Effect in Patients With Kidney Impairment
NCT01327378 ·Status: COMPLETED
-
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
NCT00938158 ·Status: COMPLETED ·Phase: PHASE1
-
SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?
NCT04853615 ·Status: UNKNOWN